In HNSCC, EGFR inhibition induces IFN pathway signaling and subsequent remodeling of the TME by increasing the expression of proinflammatory (CXCL10) and/or immunosuppressive (IL6) chemokines and cytokines (58). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.